Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1428 (LINC01428) is a member of the long intergenic non-coding RNA (lincRNA) class, which are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs, including LINC01428, may help modulate gene expression by remodelling chromatin, regulating transcription, stabilizing RNA, influencing genome architecture, and sometimes exerting enhancer-like activity, with considerable tissue specificity. As of current knowledge, there is no evidence that LINC01428 is directly linked to specific diseases, is a therapeutic target, or interacts with drugs, and its detailed functional roles have not been specifically described in the literature[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1428 (LINC01428).